Christoph I. Lee

Christoph I. Lee

Auto-generated profile, based on publicly available information

Christoph I. Lee

Department of Radiology, University of Wisconsin School of Medicine and Public Health , Madison, WI

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2004 in Radiology
Verified
Journal Article
Closed access
CLChristoph I. Lee
Christoph I. Lee
AHAndrew H. Haims
Andrew H. Haims
EMEdward P. Monico
Edward P. Monico
JBJames A. Brink
James A. Brink
HFHoward P. Forman
Howard P. Forman
To determine the awareness level concerning radiation dose and possible risks associated with computed tomographic (CT) scans among patients, emergency department (ED) physicians, and radiologists. Adult patients seen in the ED of a U.S. academic medical center during a 2-week period with mild to moderate abdominopelvic or flank pain and who underwent CT were surveyed after acquisition of the CT scan. Patients were asked whether or not they were informed about the risks, benefits, and radiation dose of the CT scan and if they believed that the scan increased their lifetime cancer risk. Patients were also asked to estimate the radiation dose for the CT scan compared with that for one chest radiograph. ED physicians who requested CT scans and radiologists who reviewed the CT scans were surveyed with similar questions and an additional question regarding the number of years in practice. The chi(2) test of independence was used to compare the three respondent groups regarding perceived increased cancer risk from one abdominopelvic CT scan. Seven percent (five of 76) of patients reported that they were told about risks and benefits of their CT scan, while 22% (10 of 45) of ED physicians reported that they had provided such information. Forty-seven percent (18 of 38) of radiologists believed that there was increased cancer risk, whereas only 9% (four of 45) of ED physicians and 3% (two of 76) of patients believed that there was increased risk (chi(2)(2) = 41.45, P <.001). All patients and most ED physicians and radiologists were unable to accurately estimate the dose for one CT scan compared with that for one chest radiograph. Patients are not given information about the risks, benefits, and radiation dose for a CT scan. Patients, ED physicians, and radiologists alike are unable to provide accurate estimates of CT doses regardless of their experience level.

3 February 2015 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
BSBrian L. Sprague
Brian L. Sprague
NSNatasha K. Stout
Natasha K. Stout
CSClyde Schechter
Clyde Schechter
NRNicolien T. van Ravesteyn
Nicolien T. van Ravesteyn
MCMucahit Cevik
Mucahit Cevik
ATAnna N.A. Tosteson
Anna N.A. Tosteson
Many states have laws requiring mammography facilities to tell women with dense breasts and negative results on screening mammography to discuss supplemental screening tests with their providers. The most readily available supplemental screening method is ultrasonography, but little is known about its effectiveness. To evaluate the benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Comparative modeling with 3 validated simulation models. Surveillance, Epidemiology, and End Results Program; Breast Cancer Surveillance Consortium; and medical literature. Contemporary cohort of women eligible for routine screening. Lifetime. Payer. Supplemental ultrasonography screening for women with dense breasts after a negative screening mammography result. Breast cancer deaths averted, quality-adjusted life-years (QALYs) gained, biopsies recommended after a false-positive ultrasonography result, and costs. Supplemental ultrasonography screening after a negative mammography result for women aged 50 to 74 years with heterogeneously or extremely dense breasts averted 0.36 additional breast cancer deaths (range across models, 0.14 to 0.75), gained 1.7 QALYs (range, 0.9 to 4.7), and resulted in 354 biopsy recommendations after a false-positive ultrasonography result (range, 345 to 421) per 1000 women with dense breasts compared with biennial screening by mammography alone. The cost-effectiveness ratio was $325 000 per QALY gained (range, $112 000 to $766 000). Supplemental ultrasonography screening for only women with extremely dense breasts cost $246 000 per QALY gained (range, $74 000 to $535 000). The conclusions were not sensitive to ultrasonography performance characteristics, screening frequency, or starting age. Provider costs for coordinating supplemental ultrasonography were not considered. Supplemental ultrasonography screening for women with dense breasts would substantially increase costs while producing relatively small benefits. National Cancer Institute.

16 February 2016 in Annals of Internal Medicine
Verified
Journal Article
Open access
DMDiana L. Miglioretti
Diana L. Miglioretti
JLJane Lange
Jane Lange
JBJeroen J. van Den Broek
Jeroen J. van Den Broek
CLChristoph I. Lee
Christoph I. Lee
NRNicolien T. van Ravesteyn
Nicolien T. van Ravesteyn
RHRebecca A. Hubbard
Rebecca A. Hubbard
This modeling study, conducted to inform the new recommendation on breast cancer screening from the U.S. Preventive Services Task Force (USPSTF), examines radiation-induced breast cancer incidence ... Background: Estimates of risk for radiation-induced breast cancer from mammography screening have not considered variation in dose exposure or diagnostic work-up after abnormal screening results. O...

1 January 2015 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
JSJohn R Scheel
John R Scheel
JLJanie M. Lee
Janie M. Lee
BSBrian L. Sprague
Brian L. Sprague
CLChristoph I. Lee
Christoph I. Lee
CLConstance D. Lehman
Constance D. Lehman

1 January 2016 in American Journal of Roentgenology
Verified
Journal Article
Closed access
CPCrystal L. Piper
Crystal L. Piper
JSJohn R Scheel
John R Scheel
CLChristoph I. Lee
Christoph I. Lee
HFHoward P. Forman
Howard P. Forman
OBJECTIVE. The purpose of this study was to describe trends over time in female authorship in the radiology literature and to investigate the tendency of female first authors to publish with female senior authors. MATERIALS AND METHODS. Data on the gender of academic physician authors based in the United States for all major articles published in three general radiology journals—Radiology, AJR, and Academic Radiology—were collected and analyzed for the years 1978, 1988, 1998, 2008, and 2013. Multivariate logistic regression was used to identify significant trends over time, and a chi-square test of independence was performed to determine significant relations between the genders of first and senior authors. RESULTS. The gender of 4182 of 4217 (99.17%) authors with MD degrees was determined. The proportion of original research articles published by women as first authors increased from 8.33% in 1978 to 32.35% in 2013 (p < 0.001). The proportion of original research articles with women as senior authors inc...

1 March 2015 in Radiology
Verified
Journal Article
Closed access
CLChristoph I. Lee
Christoph I. Lee
MCMucahit Cevik
Mucahit Cevik
OAOguzhan Alagoz
Oguzhan Alagoz
BSBrian L. Sprague
Brian L. Sprague
ATAnna N. A. Tosteson
Anna N. A. Tosteson
CLConstance D. Lehman
Constance D. Lehman
To evaluate the effectiveness of combined biennial digital mammography and tomosynthesis screening, compared with biennial digital mammography screening alone, among women with dense breasts. An established, discrete-event breast cancer simulation model was used to estimate the comparative clinical effectiveness and cost-effectiveness of biennial screening with both digital mammography and tomosynthesis versus digital mammography alone among U.S. women aged 50-74 years with dense breasts from a federal payer perspective and a lifetime horizon. Input values were estimated for test performance, costs, and health state utilities from the National Cancer Institute Breast Cancer Surveillance Consortium, Medicare reimbursement rates, and medical literature. Sensitivity analyses were performed to determine the implications of varying key model parameters, including combined screening sensitivity and specificity, transient utility decrement of diagnostic work-up, and additional cost of tomosynthesis. For the base-case analysis, the incremental cost per quality-adjusted life year gained by adding tomosynthesis to digital mammography screening was $53 893. An additional 0.5 deaths were averted and 405 false-positive findings avoided per 1000 women after 12 rounds of screening. Combined screening remained cost-effective (less than $100 000 per quality-adjusted life year gained) over a wide range of incremental improvements in test performance. Overall, cost-effectiveness was most sensitive to the additional cost of tomosynthesis. Biennial combined digital mammography and tomosynthesis screening for U.S. women aged 50-74 years with dense breasts is likely to be cost-effective if priced appropriately (up to $226 for combined examinations vs $139 for digital mammography alone) and if reported interpretive performance metrics of improved specificity with tomosynthesis are met in routine practice.